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Abstract
Septoria tritici blotch (STB; Zymoseptoria tritici) is the most important leaf disease of wheat in Northern and Western Europe. 
The problem of fungicide resistance in Z. tritici populations is challenging future control options. In order to investigate dif-
ferences in azole performances against STB, 55 field trials were carried out during four seasons (2015–2018). These trials 
were undertaken in ten different countries across Europe covering a diversity of climatic zones and agricultural practices. 
During all four seasons, four single azoles (epoxiconazole, prothioconazole, tebuconazole and metconazole) were tested. 
Increasing variability in the performances of these azoles against STB was observed across Europe. The efficacy of the tested 
azoles varied considerably across the continent and between countries. The shifts in disease control from these commonly 
used azoles were confirmed by increasing  EC50 values for epoxiconazole, prothioconazole-desthio and metconazole. The 
sensitivity towards tebuconazole remained relatively low across the four years. The frequencies of CYP51 mutations varied 
substantially across Europe, with a clear pattern of significantly decreasing frequencies of D134G, V136A and S524T in the 
local Z. tritici populations from west to east. In contrast, no major differences were seen for CYP51 mutations V136C, A379 
and I381V. The four azoles showed different levels of cross-resistance, which again depended on specific CYP51 mutations. 
Across the four seasons, the single azoles increased the yields between 9 and 11% on average.
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Introduction
Septoria tritici blotch (STB) caused by Zymoseptoria trit-
ici is the most significant yield-reducing disease in West-
ern Europe (Jørgensen et al. 2014). Fungicides are inten-
sively used to reduce losses from this disease, since only 
partly resistant cultivars are available and other cultural 
means of reducing disease severity, like delayed sowing, 
give only moderate reductions in disease epidemics (Glad-
ders et al. 2001; Jørgensen et al. 2014). The ability of the 
pathogen to produce large quantities of inoculum that can 
be spread rapidly between fields and also between regions 
makes it challenging to use traditional agronomic prac-
tices, like altered crop rotations, to minimise this pathogen 
(McDonald and Mundt 2016).
Depending on the season and region, winter wheat 
crops in Europe are typically treated with fungicides 
between one and four times per season. The critical fun-
gicide applications for control of STB target the two upper 
leaves, which are known to be most important for retaining 
yields (Lupton 1972). This high reliance on fungicides 
is controversial and problematic, in light of the general 
public’s wish for less dependence on pesticides. Notably, 
the expected restrictions on the number of pesticides avail-
able in the EU highlight the precarious current situation 
(Jess et al. 2014). Additionally, the increasing problems 
with fungicide resistance in Z. tritici populations to several 
active ingredients (AHDB 2018; Gisi et al. 2005; Torriani 
et al. 2015) present a challenge to wheat production in 
Europe in the future.
Due to the reasons mentioned above, European grow-
ers have few fungicide groups at hand for the control of 
STB. Currently, these include multi-site inhibitors such as 
folpet, chlorothalonil, sulphur and the single site azoles 
(e.g. prothioconazole, epoxiconazole, tebuconazole) and 
succinate dehydrogenase inhibitors (SDHIs) (e.g. bixafen, 
fluxapyroxad, fluopyram). In several studies, it has been 
shown that European Z. tritici populations have acquired 
different degrees of resistance to both azoles and SDHIs, 
which increases the problem of managing the disease 
(Blake et al. 2018; Cools and Fraaije 2013; Dooley et al. 
2016; Garnault et al. 2019; Heick et al. 2017a). The qui-
none outside inhibitors (QoIs) no longer provide reliable 
control of STB in Western Europe, although they might 
still be effective in some areas in Eastern Europe (Jør-
gensen et al. 2017; Mäe et al. 2020). The most effective 
and most widely used multi-site inhibitor, chlorothalonil, 
will disappear as a control option in the EU after 2020, 
leaving a major gap in options for adding efficient multi-
site inhibitors.
Azole resistance in the Z. tritici population is well doc-
umented and linked to multiple molecular mechanisms. 
Alterations in the target site, overexpression of the target 
site and overexpression of efflux pumps are among the pre-
dominate mechanisms (Cools and Fraaije 2013). Altera-
tions associated with reductions in azole sensitivity have 
been reported in European Z. tritici populations since the 
early 1990s (Zhan et al. 2008). Mutations leading to alter-
ations D134G, V136A/C/G, A379G, I381V, S524T and 
deletions at amino acid position 459–460 are claimed to 
have the highest effect on the sensitivity to azoles (Cools 
et al. 2011). These typically occur in combination, and 
the presence or absence of a single mutation can impact 
the isolates’ level of resistance substantially, with over 30 
different CYP51 haplotypes reported (Cools and Fraaije 
2013; Huf et al. 2018).
The changes in field efficacy of azoles against STB have, 
to a great extent, been associated with these CYP51 muta-
tions and elevated  EC50 values for several azoles (Blake et al. 
2018; Huf et al. 2018). The level of resistance is found to be 
highly influenced by the intensity of fungicide input in the 
control programme, which reflects the on-site risk of STB 
(Heick et al. 2017b; Jørgensen et al. 2017). Major resistance 
shifts occurring in field populations of Z. tritici initially had 
little or no effect on the field performance of epoxiconazole 
and prothioconazole. However, the efficacy of these com-
pounds has been declining in recent years (Blake et al. 2018; 
Kildea et al. 2019; Jørgensen et al. 2017).
The overall goal of the current study was to generate 
updated efficacy profiles of azoles, which have been com-
monly used for STB control in wheat across Europe over 
a long period. More specifically, the study aims were (1) 
to investigate the field performances of major single azoles 
against the current Z. tritici populations across Europe, (2) 
to elucidate the interrelation of azole field performances, in-
vitro sensitivity of Z. tritici populations and CYP51 mutation 
frequencies across Europe, (3) to discuss this interrelation-
ship between  EC50 values, specific CYP51 mutations and 
field performances.
The Eurowheat azole project is a follow-up study to a 
previous collaboration in the EuroWheat group—initiated 
by activities in the European Network of excellence—
ENDURE (Jørgensen et al. 2014). The data of the first two 
seasons of this network (2015 and 2016) have been pub-
lished previously and highlighted a high level of diversity 
in efficacy across Europe (Jørgensen et al. 2018). The addi-
tion of data from two additional seasons (2017 and 2018) 
has enabled a further examination of this variability, with a 
focus on how efficacy, sensitivity and CYP51 mutations have 
changed across the four seasons and further exploration of 
the potential links between these parameters.




The current study was carried out over the field seasons 
of 2015, 2016, 2017 and 2018 at locations across Europe, 
covering a variety of different climate zones and agricul-
tural practices. A total of 66 trials were carried out fol-
lowing similar protocols, where specific treatments were 
tested at all seasons and sites (Table 1). Of those 66 trials, 
55 provided usable data on STB, of which 19 trials were 
conducted in 2015, 12 trials in 2016, 11 trials in 2017 
and 13 trials in 2018 (Tables 2, 3). The trials were carried 
out in Denmark (DNK), Scotland (SCT), England (ENG), 
Poland (POL), France (FRA), Germany (DEU), Ireland 
(IRL), Belgium (BEL), Latvia (LVA) and Hungary (HUN) 
by local scientific organisations (Table 3). All experiments 
were carried out using standard EPPO procedures (Oepp/
Eppo 2014a) and a randomised plot design with a mini-
mum plot size of 10  m2 and three to four replicates. Winter 
wheat varieties with moderate to high susceptibility to 
STB were chosen for all trials. Equipment used for fungi-
cide applications varied from knapsack sprayers to self-
propelled sprayers. Fungicides were applied at a pressure 
of 1.8–4 bar and water volumes of 196–300 L/ha. The four 
azoles were applied at flag leaf emergence at growth stage 
(GS) 37–39 BBCH (Lancashire et al. 1991). In several 
cases, the trials were treated with cover sprays to reduce 
early infections of powdery mildew (Blumeria graminis), 
yellow rust (Puccinia striiformis) and STB as required. In 
order to prevent early outbreaks of STB, powdery mildew 
and yellow rust, chlorothalonil, metrafenon and pyraclos-
trobin were applied respectively, no later than GS 32.
The assessments were done following the EPPO guide-
line “Foliar and ear diseases on cereals” (1/26 (4)) (OEPP/
EPPO 2014a), which provides two acceptable methods using 
either individual leaves assessments from 10 to 20 tillers per 
plot or a crop stand assessment using an average scoring per 
plot. Severity was assessed as percent symptomatic area. The 
emphasis was on the assessments carried out at 30–45 days 
after application (DAA), GS 73–83 on flag leaf (FL) and flag 
Table 1  Trial protocol tested 
across all locations with 
application at GS 37–39
Fungicide doses (L/ha), amount of active ingredient (g/ha) and per cent of full rate (% N)
Treatments L/ha Active ingredient g/ha (% N) Year
Untreated – – 2015, 2016, 2017, 2018
Proline EC 250 0.8 Prothioconazole (PTH) 200 (100%) 2015, 2016, 2017, 2018
Caramba 60 1.5 Metconazole (MCA) 90 (100%) 2017, 2018
Caramba 90 1.0 90 (100%) 2015, 2016
Folicur EW 250 1.0 Tebuconazole (TCA) 250 (100%) 2015, 2016, 2017, 2018
Opus Max 1.5 Epoxiconazole (ECA) 125 (100%) 2015, 2016, 2017, 2018
Table 2  The number of trials 
included in the specific years, 
regions and combinations of 
years and regions in datasets 
used for analyses of STB 
severity  EC50 values, CYP51 
mutation frequencies and 
principal component analysis 
(PCA)
Trials per dataset Trials per 
region
Trials per year Region × year East North South West
STB severityl: 43 East 10 2015 14 2015 4 3 5 2
North 8 2016 10 2016 2 2 3 3
South 15 2017 9 2017 2 2 3 2
West 10 2018 10 2018 2 1 4 3
EC50: 46 East 10 2015 15 2015 3 4 3 5
North 9 2016 11 2016 3 2 2 4
South 11 2017 9 2017 1 1 3 4
West 16 2018 11 2018 3 2 3 3
Mutations: 46 East 11 2015 15 2015 4 4 3 4
North 8 2016 12 2016 3 2 3 4
South 12 2017 10 2017 2 1 3 4
West 15 2018 9 2018 2 1 3 3
PCA: 34 East 7 2015 11 2015 3 3 3 2
North 7 2016 9 2016 2 2 2 3
South 11 2017 7 2017 1 1 3 2
West 9 2018 7 2018 1 1 3 2
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leaf minus one (F-1). All trials were carried through to har-
vest. Grain yields were measured for every plot and adjusted 
to 85% dry matter. Fungicides were supplied by BASF SE 
(Limburgerhof, Germany) and applied at full recommended 
label rates (Table 1).
CYP51 mutation frequencies and  EC50 values
Leaf samples (2 × 10 leaves per replicate) with STB symp-
toms from 46 trials were collected at GS 65–75 from 
untreated plots. One of the two samples per plot was for-
warded to BASF SE (Limburgerhof, Germany) for mutation 
analysis and the other one to EpiLogic (Freising, Germany) 
for sensitivity analysis. DNA was extracted based on a bulk 
sample of leaves (40 leaves) merged from the four repli-
cates. The following five CYP51 mutations were tested using 
pyrosequencing: D134G, V136A/C, A379G and I381V, 
while S524T was detected using qPCR (Stammler et al. 
2012; Sierotzki et al. 2019). These mutations were selected 
as they have previously been associated with decreases in 
azole sensitivity throughout Europe (Stammler et al. 2008; 
Leroux and Walker 2011; Cools and Fraaije 2013).
With some exceptions, ten single pycnidium isolates were 
tested per site for their sensitivity to epoxiconazole (ECA), 
prothioconazole-desthio (PTH-D), metconazole (MCA) and 
tebuconazole (TCA) using a microtitre plate assay following 
the ’SEPTTR microtitre monitoring method BASF 2009 v. 
1’ (FRAC 2009). Seven days after inoculation, the growth 
is measured in a photometer at 405 nm. The values are cor-
rected by comparison with the blanks.  EC50 values are cal-
culated by probit analysis. In total, 403 isolates were tested 
across the four seasons (Table 4).
Statistical analysis
Out of the 66 trials, which all included the testing of the four 
azoles, 55 trials provided some useable data, either disease 
data (dataset 1), sensitivity data (dataset 2) or mutation data 
(dataset 3) (Tables 2, 4). In dataset 1, 43 of these 55 trials 
were included as minimum 5% STB severity in the untreated 
control and significant yield increases were used as the cri-
teria for selection. The minimum disease severity was based 
on common efficacy practise, where lower disease severity 
is seen as too unreliable for efficacy evaluation as also stated 
in EPPO guidelines (OEPP/EPPO PP 1/226 2014b). Several 
trials were affected by desiccation during the dry season 
of 2018, and thus, significant yield increases were used as 
standardised way of selecting reliable trials. In total, 46 tri-
als were included in datasets 2 and 3. In specific trials, no 
data on  EC50 values and/or mutations could be obtained. In 
some cases, it was not possible to isolate single strains from 
leaf samples, which resulted in a complete lack of sensitiv-
ity data.
Based on observed patterns of field efficacy,  EC50 val-
ues and CYP51 mutations, these data were subdivided into 
geographical regions: East: Poland, Latvia, Hungary. North: 
Denmark, Northern Germany. South: France, Belgium, 
Southern Germany. West: England, Scotland, Ireland.
Statistical analyses of CYP51 mutation frequencies, 
 EC50 values, field efficacy and yield data were carried out 
using RStudio version 1.2.5019 (RStudio Team 2019) with 
α = 0.05 for all tests. In certain cases, outliers were removed 
from specific trials. Nevertheless, proper residuals could 
not be obtained for these variables. Therefore, the non-par-
ametric kruskal.test with post-hoc dunnTest of the FSA R 
packages (R Core Team 2017) was used for distinguishing 
significant differences between levels of the factors "year" 
and "region" and their interactions.
The correlations between the sensitivity of the isolate 
collections and the four azoles were illustrated by pair-wise 
scatter plots, and correlation coefficients (Pearson’s r) were 
calculated. P values for the correlations were tested for with 
Holm’s correction for multiple tests using corr.test of the 
psych R package.
Furthermore, correlations between mutations,  EC50 val-
ues and field effects were explored using principal compo-
nents analysis (PCA). Two outliers were identified visu-
ally with scoreplot and qqPlot of the pls and car packages, 
respectively. PCA biplots of the first two principal compo-
nents were created from standardised data using the ggbi-
plots package. Ellipses corresponding to 95% confidence 
intervals of regions were also added using this function.
Results
Control of STB across Europe
Forty-three trials had levels of STB severity which allowed 
evaluation of treatment effects. The data were organised into 
four groups based on the geographical regions as well as 
the split between years (Fig. 1). STB severities were moder-
ate to high in most trials. On flag leaves, severities varied 
between 5 and 50% and on F-1 between 10 and 80%. STB 
severities were generally lower in the Eastern region, but 
Table 4  The number of pycnidial isolates of Z. tritici used for the 
analyses of  EC50 values for the four azoles
Year × region East North South West Total
2015 30 40 29 50 149
2016 6 16 17 32 71
2017 10 10 30 34 84
2018 24 20 25 30 99
Total 70 86 101 146 403
Journal of Plant Diseases and Protection 
1 3
apparent variation was also observed between years. Disease 
severity in 2018 was particularly low as a result of dry con-
ditions in Northern and Western Europe. These data were 
not statistically analysed as the STB severity data depend 
on many factors, of which climate, cultivar susceptibility 
and day of assessment after application are regarded as the 
most important.
Field trial data from 2015 to 2018 showed that the vari-
ation in efficacy of ECA, PTH and MCA increased during 
this period, as seen in Fig. 2. The results from analyses of 
main effects of region and interaction effects (year × region) 
are also presented in Fig. 2. The control levels of ECA var-
ied between 9 and 95%, of PTH between 12 and 95%, of 
MCA between 0 and 87% and of TCA between 0 and 88%. 
Efficacy levels of PTH were significantly higher in Eastern 
Fig. 1  Average septoria leaf blotch severity (% symptomatic leaf 
area) in untreated plots in specific years (2015–2018) and regions 
of Europe on FL (left) and F-1 (right) at GS 67–85, 64–50 DAA. A 
total of 43 trials were included. East: Poland, Latvia, Hungary. North: 
Denmark, Northern Germany. South: France, Belgium, Southern 
Germany. West: England, Scotland, Ireland
Fig. 2  Efficacy of four azoles across four regions in Europe and in 
4  years (2015–2018) assessed on FL and F-1 at GS 67–85, 64–50 
DAA. East: Poland, Latvia, Hungary. North: Denmark, Northern Ger-
many. South: France, Belgium, Southern Germany. West: England, 
Scotland, Ireland. Different letters represent statistically significant 
differences between regions (above boxplots) and their interaction 
with years (below boxplots) (P = 0.05). Epoxiconazole = ECA, pro-
thioconazole = PTH, metconazole = MCA and tebuconazole = TCA 
 Journal of Plant Diseases and Protection
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than in the other regions (not considering the interaction 
with years), while ECA was significantly more effective in 
Eastern and Northern Europe than the other regions. MCA 
was significantly more effective in Eastern than in North-
ern and Southern Europe, whereas the effects of this azole 
in Western Europe could not be statistically distinguished 
from those in the other regions. The efficacy of TCA also 
varied between years, but no apparent and significant dif-
ferences were seen between the four regions. On average, 
ECA, PTH, TCA and MCA gave 61%, 64%, 59% and 55% 
control, respectively, indicating very similar control against 
STB across Europe overall. However, the ranking varied 
substantially between localities, as seen in the supplemen-
tary table (S-1). When analysing the main effects of years, 
significant differences between obtained efficacies were only 
seen for PTH and MCA, whereas differences were not sig-
nificant for ECA and TCA (Table 5). Indications of declin-
ing efficacies mainly occurred in the Western and Northern 
regions (Fig. 2). Analysis of the interactions between years 
and regions is produced on a few significant differences.
EC50 values for azoles
The number of isolates of Z. tritici varied between 
years and regions but generally fell between 70 and 
149 (Table 4). ECA had  EC50 values between 0.05 and 
1.40  ppm, PTH-D between 0.01 and 0.42  ppm, MCA 
between 0.05 and 0.94 ppm and TCA between 0.37 and 
8.00 ppm.  EC50 values for the four azoles showed sig-
nificant differences across the different regions. Figure 3 
Table 5  Significant differences between STB severities and  EC50 in 
2015–2018
Different letters represent statistically significant differences 
(P = 0.05). NS, no significant differences. No significant differences 
were found between mutation frequencies in the different years
2015 2016 2017 2018
STB control
 ECA NS NS NS NS
 PTH A A B A
 TCA NS NS NS NS
 MCA A AB B A
EC50
 ECA A B B B
 PTH-D A B B B
 TCA A A A B
 MCA A B B C
Fig. 3  EC50 values for the four azoles across Europe from 2015 to 
2018. East: Poland, Latvia, Hungary. North: Denmark, Northern Ger-
many. South: France, Belgium, Southern Germany. West: England, 
Scotland, Ireland. Different letters represent statistically significant 
differences between regions (above boxplots) and their interaction 
with years (below boxplots) (P = 0.05). Epoxiconazole = ECA, pro-
thioconazole-desthio = PTH-D, metconazole = MCA and tebucona-
zole = TCA 
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shows an overall increase of  EC50 values for three of the 
four azoles from 2015 to 2018. The increase was appar-
ent for ECA, PTH-D and MCA with Western Europe 
representing the highest values. The pattern of increas-
ing  EC50 values was steep and similar for ECA and PTH-
D, but slightly more moderate for MCA. The pattern of 
 EC50 values for TCA differed compared to the other three 
azoles, where no significant increases were seen across 
years or regions. Southern Europe did, however, show a 
Z. tritici population that was significantly more sensitive 
to TCA compared with all other regions when consider-
ing the main effects of region (Fig. 3). Considering the 
main effects of years; the sensitivity of Z. tritici isolates 
changed significantly to all four azoles between 2015 and 
2018 (Table 5).
The correlations between the  EC50 values of the four 
azoles are shown in Fig. 4, and the statistical correlations 
are given in Table 5. PTH-D showed a high degree of 
cross-resistance to ECA (r = 0.89) and to MCA (r = 0.46). 
 EC50 values of TCA and ECA were not significantly cor-
related (r = 0.08), while those of TCA and PTH-D were 
negatively correlated to a small degree (r = − 0.19). More 
pronounced was the cross-resistance between TCA and 
MCA (r = 0.65) (Table 6).  
When the  EC50 values are marked depending on region 
(Fig. 4, upper part), a clear grouping can be seen. In East-
ern Europe,  EC50 values for ECA and MCA were cluster-
ing together in the lower, and TCA in the higher end of 
the scale, than in Western Europe in particular. When tak-
ing V136A frequencies into account (Fig. 4, lower part), 
similar groupings of the data are seen. This mutation was 
found at high frequencies in the population of Western 
Europe and low frequencies in Eastern Europe, indicat-
ing that TCA shows a higher degree of cross-resistance 
with both PTH-D, ECA and MCA, when the frequency of 
V136A increases.
CYP51 mutations
Analyses of DNA from bulked leaf samples revealed a vari-
able distribution of the six CYP51 mutations tested (Fig. 5). 
S524T varied significantly between the regions, and the 
overall frequency increased during the trial period in the 
Southern and Western regions (Fig. 5). In the UK and Ireland 
(grouped as ’west’), the frequency of S524T increased most 
during the four seasons from 35 to 60%. However, no sig-
nificant differences were found between years for any of the 
regions. Overall, I381V was the most common mutation, at 
an average frequency of 94% of all investigated populations 
Fig. 4  Correlations between 
log-transformed  EC50 values of 
the azoles ECA, MCA, TCA 
and PTH-D across Europe. Data 
points below the diagonal are 
colour-coded by frequencies of 
the CYP51 mutation V136A (%) 
and above the diagonal by Euro-
pean regions (East: Poland, Lat-
via, Hungary; North: Denmark, 
Northern Germany; South: 
France, Belgium, Southern Ger-
many; West: England, Scotland, 
Ireland). Epoxiconazole = ECA, 
prothioconazole-desthio = PTH-
D, metconazole = MCA and 
tebuconazole = TCA 
Table 6  Pearson’s correlation coefficients (below the diagonal) and P 
values adjusted for multiple tests (above the diagonal) for log-trans-
formed  EC50 values of the azoles ECA, MCA, TCA and PTH-D
ECA MCA TCA PTH-D
ECA – 0.00 0.24 0.00
MCA 0.70 – 0.00 0.00
TCA 0.08 0.65 – 0.00
PTH-D 0.89 0.46 − 0.19 –
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collected from trial sites in all countries. Very similar fre-
quencies of this mutation were seen in all regions, but those 
of the Western region were significantly higher. The level of 
V136C was relatively low and quite similar across all years 
and regions with an average of ca. 20%. The A379G muta-
tion was detected at similar frequencies, approximately 20%, 
during the four seasons, and no significant differences were 
measured between regions or seasons. The two mutations 
D134G and V136A were detected at comparable frequen-
cies in the medium range at most localities. The exceptions 
were Poland, Hungary and Latvia (’east’) with around 10%. 
The frequencies of D134G and V136A varied significantly 
between ’east’ compared to ’south’ and ’west’. There was a 
trend towards increasing frequencies of V136A from 2015 
to 2018, although yearly differences were not significant.
Link between parameters
A principal component analysis was performed to identify 
putative relationships between field efficacy of specific 
azoles on STB, their  EC50 values, as well as frequencies of 
CYP51 mutations identified in the local populations (Fig. 6). 
An apparent link between specific CYP51 mutations and 
 EC50 values was identified, particularly for ECA, PTH-D 
and MCA and mutations D134G, V136A, V136C, I381V 
and S524T. PTH-D and S524T were highly positively cor-
related. TCA correlated with A379G as the only one of the 
four azoles.
The PCA showed low correlation between  EC50 values 
and field performances for control of STB, except for TCA, 
for which field performance and  EC50 values were highly 
negatively correlated. Again, the specific points showed 
an obvious grouping identifying differences between the 
regional populations, which were most marked for the West-
ern and Eastern populations.
Yield responses from azole treatments
Yield data of 43 trials are summarised in Fig. 7, only includ-
ing trials with considerable STB severity and statistically 
significant yield increases. The overall yield level in control 
plots was ca. 80 dt/ha with a range from 25 to 108 dt/ha. As 
for efficacy, the average yield responses for the four azoles 
were significant and very similar, although again showing 
Fig. 5  Frequencies of the 
CYP51 mutation S524T, I381V, 
V136C, A379G, V136A, 
D134G (%) across Europe from 
2015 to 2018. East: Poland, 
Latvia, Hungary. North: 
Denmark, Northern Germany. 
South: France, Belgium, South-
ern Germany. West: England, 
Scotland, Ireland. Different 
letters represent statistically 
significant differences between 
regions (above figures) and their 
interaction with years (inside 
figures) (P = 0.05). NS, no 
significant differences
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between year variations. Average yearly yield increases 
ranged from 5.4 to 10.9 dt/ha equivalent to 9–11%. Overall, 
no significant differences were found between the increases 
from the four azoles when testing for year as the main effect.
Discussion
The azole fungicide group has been used for control of fun-
gal leaf diseases in wheat for more than four decades. Today, 
it is still considered one of the core groups in control strate-
gies, with one to four of the fungicide applications applied to 
winter wheat including an azole component. Despite prob-
lems with resistance in the European population of Z. tritici, 
the azole fungicides are still widely used for control of STB 
as well as rust diseases in European winter wheat crops. The 
most common azoles are ECA, PTH, TCA and MCA used 
either as solo products, or more often as mixing partners 
with SDHI fungicides.
In this study, data from 43 field trials located across 
Europe confirmed that the efficacy of ECA, PTH, TCA and 
MCA against STB overall has become more variable and 
declined from 2015 to 2017. The data from 2018 with low 
disease levels generally did not show any further decrease 
in efficacy. The data provided in this paper are in line with 
the previous findings showing that the efficacy of individual 
azoles has declined (Kildea 2016; Blake et al. 2018; Heick 
et al. 2020) and varies substantially across Europe with 
reduced effects from east to west (Jørgensen et al. 2018). 
On average, ECA, PTH, TCA and MCA gave very similar 
control of around 60% against STB. However, control levels 
varied considerably between localities and years. In approxi-
mately 30% of the trials, the azoles gave below 50% control 
of STB. Such levels of control are markedly inferior to other 
options for STB control. In a few cases, control levels were 
close to minimal efficacy, e.g. specific trials in England, 
France and Germany where disease reduction was below 
30% (Table S-1). The field data also indicate that TCA does 
not behave as the other azoles and its efficacy has not signifi-
cantly changed or decreased during the study period across 
regions. In specific trials from certain sites, e.g. Ireland and 
Belgium, TCA has even proved to be the best performing 
azole (Fig. 2, Table S-1). These results confirm previous 
studies, which indicated that the performance of TCA has 
stabilised, or even improved in some regions (Heick et al. 
2020). This in stark contrast to the initial drop in efficacy 
for TCA, seen around 2004–2006 in several regions in 
Western Europe (Clark 2006; Jørgensen et al. 2016). The 
data in this study indicated that various regions might have 
had distinct and different changes of efficacy from 2015 to 
2018. In particular, Northern and Southern Europe seemed 
to have almost opposing changes in efficacy from 2016 to 
2018 for ECA, PTH and MCA. Nevertheless, the interac-
tion between years and regions produced only a few signifi-
cant differences. This could be due to the weakness of the 
non-parametric test used for the statistical analysis, which 
does not reflect the high degree of variation characterising 
the data. Even though a parametric test might have revealed 
Fig. 6  Principal component analysis including the variables: Field 
effects of azoles against septoria tritici blotch (ECA STB, PTH STB, 
TCA STB and MCA STB),  EC50 of ECA, TCA, MCA and PTH-D 
and CYP51 mutation frequencies (D134G, V136A, V136C, A379G, 
I381V and S524T). Observations are shown as points and variables 
as vectors in the PC1-PC2 plane. PC axes are in s.d. units (explained 
variance in %). Ellipses: 95% confidence intervals of regions. Sym-
bols: years 2015–2018. Epoxiconazole = ECA, prothioconazole-
desthio = PTH-D, metconazole = MCA and tebuconazole = TCA 
Fig. 7  Yield of 43 trials from 2015 to 2018. Different letters rep-
resent statistically significant differences between treatments 
(above boxplots) and their interaction with years (below boxplots) 
(P = 0.05). Untreated = Untr, Epoxiconazole = ECA, prothioconazole-
desthio = PTH-D, metconazole = MCA and tebuconazole = TCA 
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more significant differences, this test would be unreliable 
since it was not possible to obtain normal distribution and 
homogeneous variance of the data.
Major differences in sensitivity have been detected in the 
in vitro testing, showing a clear gradient from east to west 
for ECA, PTH-D and MCA (Fig. 4), although not for TCA. 
The data suggest a clear link between the changes in the 
sensitivity measured in vitro and the reduced azole field per-
formances against STB across Europe during the course of 
the study. The field performance of TCA showed a different 
pattern compared to the three other azoles, since no signifi-
cant differences were found between efficacy in the different 
regions and years as main effects. The patterns of in vitro 
TCA sensitivity were generally similar across regions, but 
the Southern region had significantly higher sensitivity on 
average. The sensitivity of Z. tritici towards TCA decreased 
significantly in 2018 across regions. When comparing data 
from across regions, results from the Southern region indi-
cated such a development, but only in the Northern and 
Western regions were these changes significant.
Overall, the data indicate a stepwise decrease in sensitiv-
ity, with less sensitive strains in the population replacing the 
more sensitive, to the point that the most sensitive strains 
in the 2015 collection from Western Europe were similar 
in sensitivity to the least sensitive in Northern, Southern 
and Eastern Europe in 2018. A recent study from Ireland, 
based on data from 2005 to 2015, also showed changes in 
sensitivity in Z. tritici (Kildea et al. 2019), and an accompa-
nying decline in the field performance of azole fungicides 
against STB. A similar pattern in UK Z. tritici populations 
was described by Blake et al. (2018). Changes in pathogen 
sensitivity have also been observed in France (Garnault et al. 
2019) and in Denmark from 2012 to 2018 with the perfor-
mance of ECA and PTH particularly affected (Heick et al. 
2017a; Heick et al. 2020).
As a result of the intensive use of azoles, fungicide resist-
ance is gradually evolving in the European Z. tritici popula-
tion, although at different rates. In areas with high disease 
pressure and intensive fungicide use, such as in Ireland and 
the UK, the adaptation of the local Z. tritici populations to 
the azoles has been faster. In the current study, the recorded 
disease level was quite similar in the Southern, Northern 
and Western part of Europe. Only the Eastern part of Europe 
had less severe intensity of STB. However, the collected 
data do confirm that a gradual erosion in efficacy has taken 
place and selection for resistance is ongoing in most parts of 
Europe, as previously highlighted (Heick et al. 2017a; Huf 
et al. 2018; Garnault et al. 2019; Mäe et al. 2020).
The current study also shows apparent differences in 
the CYP51 mutations across Europe for specific regions. 
Although in general, the frequencies of the CYP51 muta-
tions, V136C, A379G and I381V have been quite stable 
across the four years, this has not been the case for other 
mutations. For example, the S524T mutation was more fre-
quent in the Western European Z. tritici population—with 
approximately 50% appearance in 2018 compared with East-
ern Europe, which had only trace levels in the populations. 
Other studies have shown that isolates with high  EC50 values 
for ECA and PTH-D carried the S524T mutation in combi-
nation with mutations like D134G and V136A (Leroux and 
Walker 2011; Cools and Fraaije 2013; Kildea et al. 2019). 
The mutations D134G and V136A are often linked and have 
now been recorded across most of Europe. Huf et al. (2018) 
concluded that strains harbouring alterations D134G and 
V136A showed a decreased sensitivity to ECA and PTH-D. 
Those strains have likely been selected for by the widespread 
use of ECA and PTH in recent years. However, strains with 
these mutations tend to have remained sensitive to other 
azoles, such as difenoconazole and TCA (Leroux and Walker 
2011; Buitrago et al. 2014). The A379G mutation was rela-
tively stable across the four seasons and the four regions. 
The principal component analysis in this study showed that 
this mutation had an adverse effect on TCA efficacy, and in 
this respect might also represent a less shifted population, 
as seen in Eastern Europe. From 2007 to 2010, isolates with 
A379G in combination with I381V dominated the European 
Z. tritici population (Stammler et al. 2008; Stammler and 
Semar 2011; Buitrago et al. 2014).
Over the past 15 years, a considerable number of muta-
tions in the CYP51 gene of Z. tritici have emerged and been 
documented (Leroux and Walker 2011; Cools and Fraaije 
2013). These mutations often occur in combinations giving 
rise to numerous haplotypes (Huf et al. 2018). The popula-
tions described in this paper reflect the overall dominance 
of the most important specific mutations based on STB 
symptoms from leaf samples and do not represent specific 
haplotypes. Full description of haplotypes requires the isola-
tion of a significant numbers of Z. tritici isolates per locality 
and full sequencing. Several of the specific haplotypes of Z. 
tritici have variable impacts on particular azoles. In a recent 
study, a new nomenclature described 33 different CYP51 
haplotypes based on a collection of 331 isolates across 
Europe. Nine of these haplotypes were found to represent 
85% of all isolates, suggesting a very heterogeneous distri-
bution across Europe (Huf et al. 2018). The most dominant 
haplotype ’E4’ carrying D134G, V136A and I381V was the 
most widespread across Europe (Huf et al. 2018).
In the present study, it should also be noted that the sensi-
tivity profile and mutation frequencies are from isolates from 
the untreated control plots. The PCA analysis could look 
somewhat different if the sensitivity and mutation frequen-
cies were from the various fungicide treatments. The main 
result from the PCA is that with a very diverse set of trials 
with extremely diverse sensitivity profiles the most common 
theme (PC1, accounting for 1/3 of the variation in the data) 
among them all was that increased mutations or decreased 
Journal of Plant Diseases and Protection 
1 3
sensitivity was inversely related to efficacy. In this study, 
we focused on development of European azole resistance 
in the Z. tritici population, but recent reports from the USA 
and Australia have also shown a delayed but still significant 
adaptation of the local Z. tritici populations towards azole 
fungicide (Sykes et al. 2018; McDonald et al. 2019).
There are currently two established theories on how azole 
resistance in Z. tritici might have spread within Europe. 
Brunner et al. (2008) proposed that resistance inducing 
CYP51 mutations emerged at a few places, perhaps in the 
UK or Denmark, from where it spread eastward due to the 
prevailing wind direction from west to east. The gradient in 
mutation frequencies across Europe identified in the pre-
sented study could support this theory. However, an alterna-
tive theory is that the variable profiles of CYP51 mutations 
in the Z. tritici populations have emerged and been selected 
for locally. This theory cannot be ruled out and, indeed, was 
shown to explain the development of STB resistance in Aus-
tralia (McDonald et al.2019). The variation in frequencies 
results from differences in disease pressure and intensity 
of fungicide use. Spread of resistance in Z. tritici popula-
tions could, however, be a combination of both theories, 
where both the spread of ascospores across vast distances in 
a prevailing wind direction in combination with the intensive 
use of fungicides drive the selection. Studies have shown 
that selection of CYP51 mutations can take place locally, 
as demonstrated in specifically designed field trials, where 
individual azoles and azole-combinations have been applied 
(Heick et al. 2017b).
While  EC50 values showed clear cross-resistance patterns 
(Fig. 4), field performance results were less clear. Field test-
ing represents a more uncertain environment, where many 
factors can influence the final efficacy. These factors include 
among others: disease levels, the timing of application, the 
timing of last assessments and the impact of other leaf dis-
eases. Similar examples of weak links between field efficacy, 
mutation frequencies and in vitro sensitivity of local Z. tritici 
populations have been reported in other studies (Stammler 
et al. 2008). Even so, in the study based on the first two years 
of data (Jørgensen et al. 2018), the best correlations between 
field efficacies were found for ECA, PTH and MCA and the 
lowest correlations between TCA and ECA and PTH. Inter-
estingly MCA correlates relatively well with all the other 
azoles. The PCA analysis presented in this paper (Fig. 6) 
again confirms a closer link between ECA, PTH and MCA, 
while TCA shows less cross-resistance.
Although a significant reduction in azole sensitivity has 
been observed in the European Z. tritici population, the azole 
fungicides still play a critical role in the control of STB across 
the continent. This role concerns both direct control of STB, 
and as a partner for the SDHIs as part of a broader anti-
resistance strategy (Dooley et al. 2016). It has been shown 
that selection for azole resistance can be reduced using spray 
strategies composed of azoles with a different cross-resistance 
pattern compared to spray strategies composed of azoles rep-
resenting only one cross-resistance group (Heick et al. 2017b). 
Jørgensen et al. (2018) demonstrated that higher STB control 
levels could be achieved from azole mixtures compared to 
the use of a single azole. Although all azoles are affected by 
sensitivity shifting and mutations, Mullins et al. (2011) have 
demonstrated that the effects of specific azoles are differently 
impacted by mutations occurring in the azole-binding pocket, 
providing variable affinity of the various azoles. However, the 
intensive use of azole mixtures has increased the risk for devel-
opment of more complex CYP51 variants. This was, for exam-
ple, the case for mixtures of prochloraz (selecting for V136A) 
and TCA (selecting for I381V), which resulted in selection 
for variants with both V136A and I381V (Lucas et al. 2015).
Other strategies to reduce the emergence of azole resist-
ance, such as diversifying the spraying strategy by including 
multi-site inhibitors or single-site inhibitors with other modes 
of action (MoA) in spray programs, can reduce azole selection 
pressure (van den Bosch et al. 2014a). Several other strategies, 
e.g. limiting the number of applications, adjusting dose rates 
and applying alternation or mixing of fungicides with differ-
ent MoA, have been described as effective tools in fungicide 
resistance management in a number of studies (van den Berg 
et al. 2013; van den Bosch et al. 2014b; Lucas et al. 2015).
In 2020, a new azole mefentrifluconazole (Bryson et al. 
2018) was introduced to the European market. This new 
active is expected to replace some of the currently available 
azoles due to its high intrinsic activity on STB, as shown 
in several trials across Europe (Jørgensen et al. 2020a). 
Although mefentrifluconazole outperformed the four tested 
azoles in the field for control of STB, in vitro studies have 
shown cross-resistance with TCA and difenoconazole (Heick 
et al. 2020). The expected introduction of the Quinone inside 
Inhibitor (QiI) fenpicoxamid (Owen et al. 2017) and a new 
generation of QoI fungicides like metyltetraprole (Suemoto 
et al. 2019) may introduce options for more diverse and suc-
cessful control of STB and reduce the overall pressure on 
using azoles.
In a previous yield response analysis, the benefit from 
the azoles was linked to the dominating disease, where the 
control of yellow rust gave rise to the biggest yield increases 
(Jørgensen et al. 2018). Yield data from trials in this project 
verify that despite the reduced efficacy of the azoles, they 
can still provide a yield benefit of around 10% when used as 
single products. Although, from a farmer’s viewpoint, this is 
still a beneficial increase, the yield benefit is inferior to other 
more efficient fungicides, such as SDHI/azole mixtures and 
the new azole, mefentrifluconazole (Jørgensen et al. 2020b). 
The drop in efficacy of azoles highlights the needs to include 
other IPM-related means of managing STB like resistant 
varieties, adjustments of sowing dates, etc.
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Conclusion
Data from four season’s azole testing across Europe showed 
variable, but still beneficial levels of STB control from the 
four included azoles at the majority of sites tested. The field 
performances have become significantly more variable in 
terms of achieved control of STB, and at 30% of the sites, 
the control was below 50%. The in vitro sensitivity of local 
Z. tritici populations to all four azoles has also decreased 
significantly during the four seasons, with a drift in sensitiv-
ity from east to west in Europe. The decrease in sensitivity 
is closely linked to key CYP51 mutations. The three azoles 
ECA, PTH and MCA showed higher levels of cross-resist-
ance than TCA.
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